Elizabeth A Marchant1,2, Bernard Kan1,2, Ashish A Sharma1,2, Alice van Zanten3,4, Tobias R Kollmann1,2,3,4, Rollin Brant1,5, Pascal M Lavoie1,2,3,4. 1. Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 2. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 3. Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. 4. Children's & Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada. 5. Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
BACKGROUND: Antimicrobial responses have been shown to be profoundly attenuated in very preterm neonates when examined on cord blood. However, we lack data on these responses at the time these neonates are most vulnerable to infections. METHODS: Multiple cytokine responses to two prototypic Toll-like receptor (TLR) agonists: lipopolysaccharide (LPS) (TLR4) and R848 (TLR7/8) were prospectively measured in preterm neonates born ≤30 wk of gestation (n = 50) during the first 28 d of age using whole blood and single-cell multiparameter flow cytometry assays. Results were compared to term neonates (n = 30) and adult controls (n = 25). RESULTS: In preterm neonates, LPS and R848 responses remained attenuated in both cord blood and in the first 28 d of age. These responses showed significant maturation over time after adjusting for gestational age and were confirmed in monocytes and dendritic cells on a per-cell basis. We detected no major contribution of chorioamnionitis, maternal antenatal corticosteroids or magnesium sulfate treatment, labor, or mode of delivery to the maturation of cytokine responses. CONCLUSION: Innate immune antimicrobial defenses are profoundly attenuated developmentally in very preterm neonates during the neonatal period, suggesting that exogenous factors drive the sustained systemic inflammation that has been linked to increased morbidities in these infants.
BACKGROUND: Antimicrobial responses have been shown to be profoundly attenuated in very preterm neonates when examined on cord blood. However, we lack data on these responses at the time these neonates are most vulnerable to infections. METHODS: Multiple cytokine responses to two prototypic Toll-like receptor (TLR) agonists: lipopolysaccharide (LPS) (TLR4) and R848 (TLR7/8) were prospectively measured in preterm neonates born ≤30 wk of gestation (n = 50) during the first 28 d of age using whole blood and single-cell multiparameter flow cytometry assays. Results were compared to term neonates (n = 30) and adult controls (n = 25). RESULTS: In preterm neonates, LPS and R848 responses remained attenuated in both cord blood and in the first 28 d of age. These responses showed significant maturation over time after adjusting for gestational age and were confirmed in monocytes and dendritic cells on a per-cell basis. We detected no major contribution of chorioamnionitis, maternal antenatal corticosteroids or magnesium sulfate treatment, labor, or mode of delivery to the maturation of cytokine responses. CONCLUSION: Innate immune antimicrobial defenses are profoundly attenuated developmentally in very preterm neonates during the neonatal period, suggesting that exogenous factors drive the sustained systemic inflammation that has been linked to increased morbidities in these infants.
Authors: Elisabeth Förster-Waldl; Kambis Sadeghi; Dietmar Tamandl; Bernadette Gerhold; Ulrike Hallwirth; Klaudia Rohrmeister; Michael Hayde; Andrea R Prusa; Kurt Herkner; George Boltz-Nitulescu; Arnold Pollak; Andreas Spittler Journal: Pediatr Res Date: 2005-05-05 Impact factor: 3.756
Authors: Capucine Picard; Horst von Bernuth; Pegah Ghandil; Maya Chrabieh; Ofer Levy; Peter D Arkwright; Douglas McDonald; Raif S Geha; Hidetoshi Takada; Jens C Krause; C Buddy Creech; Cheng-Lung Ku; Stephan Ehl; László Maródi; Saleh Al-Muhsen; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; Noorbibi K Day-Good; Steven M Holland; John I Gallin; Helen Chapel; David P Speert; Carlos Rodriguez-Gallego; Elena Colino; Ben-Zion Garty; Chaim Roifman; Toshiro Hara; Hideto Yoshikawa; Shigeaki Nonoyama; Joseph Domachowske; Andrew C Issekutz; Mimi Tang; Joanne Smart; Simona Eva Zitnik; Cyrille Hoarau; Dinakantha S Kumararatne; Adrian J Thrasher; E Graham Davies; Claire Bethune; Nicolas Sirvent; Dominique de Ricaud; Yildiz Camcioglu; Júlia Vasconcelos; Margarida Guedes; Artur Bonito Vitor; Carlos Rodrigo; Francisco Almazán; Maria Méndez; Juan Ignacio Aróstegui; Laia Alsina; Claudia Fortuny; Janine Reichenbach; James W Verbsky; Xavier Bossuyt; Rainer Doffinger; Laurent Abel; Anne Puel; Jean-Laurent Casanova Journal: Medicine (Baltimore) Date: 2010-11 Impact factor: 1.889
Authors: Janet Elizabeth Berrington; Richard Iain Hearn; Mary Bythell; Chris Wright; Nicholas David Embleton Journal: J Pediatr Date: 2011-08-24 Impact factor: 4.406
Authors: Ofer Levy; Kol A Zarember; Rene M Roy; Colette Cywes; Paul J Godowski; Michael R Wessels Journal: J Immunol Date: 2004-10-01 Impact factor: 5.422
Authors: Boris W Kramer; Machiko Ikegami; Timothy J M Moss; Ilias Nitsos; John P Newnham; Alan H Jobe Journal: Am J Respir Crit Care Med Date: 2004-10-01 Impact factor: 21.405
Authors: Andrew J Currie; Donald J Davidson; Gregor S D Reid; Simi Bharya; Kelly L MacDonald; Rebecca S Devon; David P Speert Journal: J Pediatr Date: 2004-04 Impact factor: 4.406
Authors: Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby Journal: Am J Reprod Immunol Date: 2017-06-20 Impact factor: 3.886
Authors: Simon D van Haren; Lakshmi Ganapathi; Ilana Bergelson; David J Dowling; Michaela Banks; Ronald C Samuels; Steven G Reed; Jason D Marshall; Ofer Levy Journal: Cytokine Date: 2016-04-12 Impact factor: 3.861
Authors: Emma de Jong; David G Hancock; Julie Hibbert; Christine Wells; Peter Richmond; Karen Simmer; David Burgner; Tobias Strunk; Andrew J Currie Journal: J Mol Med (Berl) Date: 2017-11-13 Impact factor: 4.599
Authors: Maria Giulia Conti; Asimenia Angelidou; Joann Diray-Arce; Kinga K Smolen; Jessica Lasky-Su; Mario De Curtis; Ofer Levy Journal: Pediatr Res Date: 2019-11-05 Impact factor: 3.756